AN2 Therapeutics, Inc. Common Stock (NASDAQ: ANTX) last traded at $4.40, down 5.98% on the session. The quote above updates while this page is open; the figures below are drawn from AN2 Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
AN2 Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ANTX. Its market capitalisation is $166.04 million.
Valuation measures for AN2 Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $166.04M |
|---|---|
| Enterprise value | $127.48M |
| Price / book | 2.19 |
| Beta | 0.49 |
Trailing-twelve-month figures tagged in AN2 Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$36.28M |
| EPS (TTM) | -$1.07 |
|---|
| Return on equity | -47.78% |
|---|
| Cash | $44.32M |
|---|
Range and volume for ANTX over the past 52 weeks.
| 52-week high | $7.19 |
|---|---|
| 52-week low | $1.00 |
| Volume | 442.1K |
| Average volume | 243.3K |
| Previous close | $4.68 |
Invest a chosen dollar amount in AN2 Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ANTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.